Jun 15, 2021
News & Events
Press Releases
Jun 7, 2021
Salarius Pharmaceuticals Presents New Research Data Demonstrating Seclidemstat’s Safety, Dosing, and Drug Activity at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
May 19, 2021
Salarius Pharmaceuticals Discloses Key Findings from Three Abstracts to be Presented at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
May 12, 2021
Salarius Pharmaceuticals Reports First Quarter Financial Results with Business Highlights
Events
NobleCon17: Panel Discussion on Targeted Cancer Therapies
During the Noble Capital Markets’ 17th Annual Small & Microcap Investor Conference, Dr. Daniela Santiesteban, Director of Research and Business Development at Salarius Pharmaceuticals, will participate in a virtual panel discussion highlighting the future of targeted cancer therapies. The panel...
Biotech Showcase Digital
https://informaconnect.com/biotech-showcase/registration-options/
A.G.P.’s Virtual Healthcare Symposium
Salarius Pharmaceuticals to Report Third Quarter 2020 Financial Results
Conference Call Information: Interested participants and investors may access the conference call by dialing either: (833) 423-0481 (U.S.) (918) 922-2375 (international) Conference ID: 1277839
In the News
Houston Business Journal